InvestorsHub Logo
Followers 80
Posts 24703
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 03/14/2017 9:04:47 AM

Tuesday, March 14, 2017 9:04:47 AM

Post# of 27622
GALT - 1.81 Pre-market now at 2.00/2.01

GR-MD-02 Demonstrates Clinically Significant Effect in Patients with Severe and Refractory Atopic Dermatitis (Eczema)



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.